NCT00667277 Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis Status TERMINATED Phase PHASE2
NCT00665067 Correlative Biomarker Study in Patients With Myeloproliferative Disorders Status COMPLETED Phase N/A
NCT00631462 A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis Status COMPLETED Phase PHASE1
NCT00606437 Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants Status COMPLETED Phase PHASE1
NCT00599547 Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients Status COMPLETED Phase PHASE2
NCT00572897 Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis Status COMPLETED Phase PHASE2
NCT00572065 Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis Status COMPLETED Phase EARLY_PHASE1
NCT00522990 Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias Status TERMINATED Phase PHASE1/PHASE2
NCT00509899 Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00475020 Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00463385 A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia Status COMPLETED Phase PHASE2
NCT00393380 Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor Status TERMINATED Phase PHASE2
NCT00360035 Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia Status COMPLETED Phase PHASE2
NCT00354120 Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant Status COMPLETED Phase PHASE2/PHASE3